|
|
Post by perrinmosca on Sept 15, 2015 14:19:43 GMT
Although its nice to have an up day, there is another gap now! They always seem to fill..... Agree, as every prior gap with ACTC/OCAT has closed.
But, we don't know when the gap will close (if this latest one does close).
Pending news (Lupus data, SPA, SMD start) could take it higher first before a retrace a little farther down the road. That said, I did sell a small amount this morning when it crossed $4.50 and was up over 7% with that new gap formed at the open. Will add more if the gap fills before news.
I really appreciate you letting us know when u trade, i think u have a good feel of this stock. Thanks! |
|
|
|
Post by jckrdu on Sept 15, 2015 14:32:45 GMT
Agree, as every prior gap with ACTC/OCAT has closed.
But, we don't know when the gap will close (if this latest one does close).
Pending news (Lupus data, SPA, SMD start) could take it higher first before a retrace a little farther down the road. That said, I did sell a small amount this morning when it crossed $4.50 and was up over 7% with that new gap formed at the open. Will add more if the gap fills before news.
I really appreciate you letting us know when u trade, i think u have a good feel of this stock. Thanks! No problem... I'll continue to post when I make major trades.
For now, I'm still holding a good sized position looking for news over the next 1-3 weeks (Lupus data, SPA, SMD start) which hopefully gets us into that higher gap from $5.88 to $6.23. I'll be lightening up if a) we get into that pps range, or b) if those news items come and the pps doesn't react as I hope.
3 month chart still looks decent and shows uptrend in tact, IMO.
|
|
|
|
Post by actcfan on Sept 15, 2015 14:37:04 GMT
Any news out there? It doesn't typically go up for no reason. It typical does go down for no reason.  |
|
|
|
Post by selluwud on Sept 15, 2015 15:17:01 GMT
I really appreciate you letting us know when u trade, i think u have a good feel of this stock. Thanks! No problem... I'll continue to post when I make major trades.
For now, I'm still holding a good sized position looking for news over the next 1-3 weeks (Lupus data, SPA, SMD start) which hopefully gets us into that higher gap from $5.88 to $6.23. I'll be lightening up if a) we get into that pps range, or b) if those news items come and the pps doesn't react as I hope.
3 month chart still looks decent and shows uptrend in tact, IMO.
Along with the news you mentioned, isn't the JV for a non-core therapy supposed to be announced before the end of the month? Even if not a financial windfall, it will give us some direction and validity to previous guidance. |
|
|
|
Post by ytseschew on Sept 15, 2015 16:04:04 GMT
No problem... I'll continue to post when I make major trades.
For now, I'm still holding a good sized position looking for news over the next 1-3 weeks (Lupus data, SPA, SMD start) which hopefully gets us into that higher gap from $5.88 to $6.23. I'll be lightening up if a) we get into that pps range, or b) if those news items come and the pps doesn't react as I hope.
3 month chart still looks decent and shows uptrend in tact, IMO.
Along with the news you mentioned, isn't the JV for a non-core therapy supposed to be announced before the end of the month? Even if not a financial windfall, it will give us some direction and validity to previous guidance. I thought that was guided to be by the end of Q4, not Q3. |
|
|
|
Post by imz72 on Sept 15, 2015 16:43:00 GMT
Along with the news you mentioned, isn't the JV for a non-core therapy supposed to be announced before the end of the month? Even if not a financial windfall, it will give us some direction and validity to previous guidance. I thought that was guided to be by the end of Q4, not Q3. You're right. This is from July presentation:  |
|
|
|
Post by selluwud on Sept 15, 2015 17:10:06 GMT
I thought that was guided to be by the end of Q4, not Q3. You're right. This is from July presentation: Oh well, fuzzy memory...........but I like my version better! There's still time to kick it down the road some more. |
|
|
|
Post by actcfan on Sept 17, 2015 12:05:15 GMT
Awfully quiet.
|
|
|
|
Post by harlem on Sept 17, 2015 14:08:07 GMT
Is SPA off the table as we have enrolled the first patient in P2? I thought SPA is given before a P2 starts.
|
|
|
|
Post by selluwud on Sept 17, 2015 14:30:56 GMT
Is SPA off the table as we have enrolled the first patient in P2? I thought SPA is given before a P2 starts. This has been discussed before, SPA is for SMD not AMD which has started enrollment. All Good. |
|
|
|
Post by selluwud on Sept 17, 2015 14:33:43 GMT
FYI: This was posted on iCell by MikeC
"Tufts Fistula (Crohn’s) Paper to be published in Regenerative Medicine October 1st
I attended Andrew Hoffman’s talk last night at Tufts Veterinary School on Regenerative Medicine.
During Q&A, I asked him the status of the autoimmune trials and when they might be published. He said that the paper on the fistula trial will be coming out in Regenerative Medicine on October 1st. Dr. Hoffman also said that he could not talk about other MSC trials because he is under a confidentiality agreement with Ocata. "
|
|
|
|
Post by harlem on Sept 17, 2015 15:46:48 GMT
Thank you selluwud... the effects of age and following this stock leave my brain in need of a shot of stem cells glta
|
|
|
|
Post by actcfan on Sept 17, 2015 15:58:12 GMT
FYI: This was posted on iCell by MikeC "Tufts Fistula (Crohn’s) Paper to be published in Regenerative Medicine October 1st I attended Andrew Hoffman’s talk last night at Tufts Veterinary School on Regenerative Medicine. During Q&A, I asked him the status of the autoimmune trials and when they might be published. He said that the paper on the fistula trial will be coming out in Regenerative Medicine on October 1st. Dr. Hoffman also said that he could not talk about other MSC trials because he is under a confidentiality agreement with Ocata. " Great news and I'm sure good results will be meaningful as they move the program forward and in partnering discussions. I am not as confident as others elsewhere that this paper alone moves the pps though. Not for more than half a day at least. Guess we will see, maybe it will come with some companion news. |
|
|
|
Post by selluwud on Sept 17, 2015 17:14:38 GMT
Thank you selluwud... the effects of age and following this stock leave my brain in need of a shot of stem cells glta You are welcome. I am not much better, maybe they will run a trial with HMC's for treating "Addled" minds for whatever the cause of the "addlement" (Drugs, booze, sex, stem cell investing, etc.......) |
|
sunny
Junior Member
Posts: 57 
|
Post by sunny on Sept 17, 2015 23:30:59 GMT
Since safety has been achieved and a placebo is in place for P2 Dry AMD, is it possible that new participants will have both eyes treated with RPE transplantation? If so, then I would imagine efficacy will be HUGE. #Cure Another thought: What if P1 patients enroll for their untreated eye. That would be like winning the Super Bowl of ophthalmology. |
|
|
|
Post by actcfan on Sept 18, 2015 2:31:20 GMT
I've wondered the same about treating both eyes. I think we should see the protocol on clinicaltrials.gov in the coming weeks.
I don't think they would re-treat P1 patients in P2
|
|
|
|
Post by CM kipper007 on Sept 18, 2015 3:21:27 GMT
I've wondered the same about treating both eyes. I think we should see the protocol on clinicaltrials.gov in the coming weeks. I don't think they would re-treat P1 patients in P2 This is still a safety trial, so treating phase 1 patients in phase 2 would mean if there was a long term severe issue with the cells, patients could lose both eyes at the worst outcome. As an extra control, treating just one eye means they get additional data to measure. |
|
|
|
Post by actcfan on Sept 18, 2015 19:38:00 GMT
Chart for the week looks pretty strong. People building into next week for some reason?
|
|
|
|
Post by jckrdu on Sept 18, 2015 20:07:26 GMT
I really appreciate you letting us know when u trade, i think u have a good feel of this stock. Thanks! No problem... I'll continue to post when I make major trades.
For now, I'm still holding a good sized position looking for news over the next 1-3 weeks (Lupus data, SPA, SMD start) which hopefully gets us into that higher gap from $5.88 to $6.23. I'll be lightening up if a) we get into that pps range, or b) if those news items come and the pps doesn't react as I hope.
3 month chart still looks decent and shows uptrend in tact, IMO.
Uptrend intact and playing out. Setting up well for a move higher (hopefully into the $5.88-$6.23 gap) next week on news.
Good weekend all.
|
|
|
|
Post by rickrick on Sept 20, 2015 18:56:48 GMT
If we don't break above 5 I'll sell and buy back on the dip. Gotta take my profits when they show up.
|
|
